glp 1 and osteoarthritis Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity? What GLP1 medications are used
Description
Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy
Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/ leptin dual agonist
These medications include semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro)
Mandalari G, Nueno-Palop C, Bisignano G, Wickham MS, Narbad A
MAESTRO-NASH Investigators
